Video Shorts

0:44
The Unknown Long-Term Impacts of GLP-1 Medications
2 months ago
by
W. Timothy Garvey, MD

0:44
New Oral GLP-1s Provide Alternatives to Injection
2 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

0:46
FDA Approves First-Of-Its-Kind Oral GLP-1 For Weight Loss
2 months ago
by
W. Timothy Garvey, MD

0:48
Single- to Multi-Food Immunotherapy Is a Natural Progression in Allergy Care
2 months ago
by
Hugh Windom, MD

0:52
Diabetes Dialogue: Predicting the Glucose Impact of Meals with Libre Assist
2 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

1:09
Diabetes Dialogue: 2026 ADA Standards of Care and Insulin Pump Use
2 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

1:10
Diabetes Dialogue: Retatrutide Reduces Body Weight 28.7% in Phase 3 Trial
2 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

1:33
Dexcom G6 is Retiring: The End of an Era for CGM Users
2 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

1:25
New Phase 3 Data Support FDA-Approved Lumateperone as Add-On in MDD
2 months ago
by
Suresh Durgam, MD

1:14
Tips on Winter Skincare Routines for Patients with Skin of Color
2 months ago
by
Heather Woolery-Lloyd, MD(+1 more)

1:02
Diabetes Dialogue: Retatrutide’s Impact on Osteoarthritis in TRIUMPH-4
2 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

1:15
QOL and Platelet Improvement With New ITP Drug
2 months ago
by
David Kuter, MD

1:11
AI Blood Test Quickly Identifies MDD Patients Fit for V1b Blocker
2 months ago
by
Hans Eriksson, MD, PhD

1:03
The Move to Treatable Traits for COPD and Asthma
3 months ago
by
Andrew (Truong-An) Ho, MD(+2 more)

0:52
Insulet Announces Next-Gen Omnipod 6 Coming in 2027
3 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

1:15
Phase 3 NATRON Trial Shows Benefits of Benralizumab for HES
3 months ago
by
Princess Ogbogu, MD

2:08
The Biggest Challenges Facing New Insulin Pumps
3 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

0:33
Using New Therapies to Address Triglycerides in FCS
3 months ago
by
Christie Ballantyne, MD

1:36
Semaglutide Misses Mark for Alzheimer Disease in evoke Trials
3 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

1:39
The Medical Sisterhood: Ways to Stay Organized
3 months ago
by
Amy Y. Chen, MD(+1 more)

1:30
Why ARNIs Were Excluded from POLY-HF
3 months ago
by
Ambarish Pandey, MD(+2 more)

1:08
The Medical Sisterhood: Balance and Boundaries in the Holiday Season
3 months ago
by
Mona Shahriari, MD, FAAD(+1 more)

1:12
Skin of Color Savvy: Hair-Care Challenges in Dermatology
3 months ago
by
Kayla Taylor, MD(+1 more)

1:07
POLY-HF's 50% Drop in Heart Failure Hospitalizations
3 months ago
by
Muthiah Vaduganathan, MD, MPH(+2 more)

0:59
Dupilumab Cuts Surgery Need in Patients with Allergic Fungal Rhinosinusitis
3 months ago
by
Amber Luong, MD, PhD

2:14
The Puzzle of Polypill Adherence
3 months ago
by
Muthiah Vaduganathan, MD, MPH(+2 more)

1:04
How to Differentiate Other Forms of Arthritis and Psoriatic Arthritis
3 months ago
by
Shikha Singla, MD

1:18
Kidney Week: DUPLEX Supports Safety of Sparsentan in Pediatric FSGS
3 months ago
by
Michelle Rheault, MD

1:08
Why Enlicitide Will Revolutionize Primary Care Prescribing
3 months ago
by
Ann Marie Navar, MD, PhD

0:46
Key Members of a Multidisciplinary Team in Heart Failure Care
3 months ago
by
David Landers, MD
Advertisement
Advertisement
Trending on HCPLive
1
Real-World HAE Control with Berotralstat at 18 Months, With Raffi Tachdjian, MD
2
Pediatric HAE Guideline Recommends Sebetralstat as First-Line Therapy
3
Mechanistic Rationale for Dual Costimulation Blockade, Belatacept, Dazodalibep in Kidney Transplantation
4
COMP360 Psilocybin Meets Primary Endpoint in Second Phase 3 Trial for TRD
5
